Evidence map›Paper›PMID 33569603›Full record

ArticleBlood2021

Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury.

Lauren G Poole, Anna K Kopec, Dafna J Groeneveld, Asmita Pant, Kevin S Baker, Holly M Cline-Fedewa, Matthew J Flick, James P Luyendyk

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Determinants of abnormal liver-related biomarkers in adult COVID-19 patients.Frontiers in cellular and infection microbiology · 2025
    Article
  6. Article
  7. Fibrinolysis-Mediated Pathways in Acute Liver Injury.Seminars in thrombosis and hemostasis · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Altered fibrinogen γ-chain cross-linking in mutant fibrinogen-γJournal of thrombosis and haemostasis : JTH · 2023
    Article
  14. Thrombus composition and thrombolysis resistance in stroke.Research and practice in thrombosis and haemostasis · 2023
    Article
  15. Fibrin clot properties and thrombus composition in cirrhosis.Research and practice in thrombosis and haemostasis · 2023
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lauren G PooleDepartment of Pathobiology & Diagnostic Investigation.
Anna K KopecDepartment of Pathobiology & Diagnostic Investigation.
Dafna J GroeneveldDepartment of Pathobiology & Diagnostic Investigation.ORCID 0000-0002-1207-5769
Asmita PantDepartment of Pathobiology & Diagnostic Investigation.ORCID 0000-0003-4468-8639
Kevin S BakerInstitute for Integrative Toxicology, and.
Holly M Cline-FedewaDepartment of Pathobiology & Diagnostic Investigation.
Matthew J FlickDepartment of Pathology and Laboratory Medicine, Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
James P LuyendykDepartment of Pathobiology & Diagnostic Investigation.
Michigan State University · USUniversity of North Carolina at Chapel Hill · US

Funding

Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated ThrombosisU01HL143403 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FISHEL, MELISSA L., FLICK, MATTHEW J. · 2018 to 2022
$4.2M
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma diseaseR01CA211098 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLICK, MATTHEW J. · 2017 to 2022
$2.2M
Novel determinants of fibrinogen pro-repair activity in acetaminophen-induced liver toxicityR01DK120289 · NIDDK · MICHIGAN STATE UNIVERSITY · PI LUYENDYK, JAMES P · 2019 to 2023
$2.2M
Fibrin(ogen) control of metabolic inflammation and obesityR01DK112778 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLICK, MATTHEW J. · 2019 to 2022
$1.5M
Integrative Training in the Pharmacological SciencesT32GM092715 · NIGMS · MICHIGAN STATE UNIVERSITY · PI NEUBIG, RICHARD R · 2011 to 2020
$1.5M
Novel mechanisms stimulating liver repair after acetaminophen overdoseR01DK105099 · NIDDK · MICHIGAN STATE UNIVERSITY · PI LUYENDYK, JAMES P · 2015 to 2018
$1.4M
Mechanisms of fibrin(ogen)-directed macrophage activation in liver toxicityF32DK121423 · NIDDK · MICHIGAN STATE UNIVERSITY · PI POOLE, LAUREN G · 2019 to 2019
$62k
NCI NIH HHS R01 CA211098NHLBI NIH HHS U01 HL143403NIDDK NIH HHS F32 DK121423NIDDK NIH HHS R01 DK105099NIDDK NIH HHS R01 DK112778NIDDK NIH HHS R01 DK120289NIGMS NIH HHS T32 GM092715
6 · The paper itself

Abstract

Intravascular fibrin clot formation follows a well-ordered series of reactions catalyzed by thrombin cleavage of fibrinogen leading to fibrin polymerization and cross-linking by factor XIIIa (FXIIIa). Extravascular fibrin(ogen) deposits are observed in injured tissues; however, the mechanisms regulating fibrin(ogen) polymerization and cross-linking in this setting are unclear. The objective of this study was to determine the mechanisms of fibrin polymerization and cross-linking in acute liver injury induced by acetaminophen (APAP) overdose. Hepatic fibrin(ogen) deposition and cross-linking were measured following APAP overdose in wild-type mice, mice lacking the catalytic subunit of FXIII (FXIII-/-), and in FibAEK mice, which express mutant fibrinogen insensitive to thrombin-mediated fibrin polymer formation. Hepatic fibrin(ogen) deposition was similar in APAP-challenged wild-type and FXIII-/- mice, yet cross-linking of hepatic fibrin(ogen) was dramatically reduced (>90%) by FXIII deficiency. Surprisingly, hepatic fibrin(ogen) deposition and cross-linking were only modestly reduced in APAP-challenged FibAEK mice, suggesting that in the APAP-injured liver fibrin polymerization is not strictly required for the extravascular deposition of cross-linked fibrin(ogen). We hypothesized that the oxidative environment in the injured liver, containing high levels of reactive mediators (eg, peroxynitrite), modifies fibrin(ogen) such that fibrin polymerization is impaired without impacting FXIII-mediated cross-linking. Notably, fibrin(ogen) modified with 3-nitrotyrosine adducts was identified in the APAP-injured liver. In biochemical assays, peroxynitrite inhibited thrombin-mediated fibrin polymerization in a concentration-dependent manner without affecting fibrin(ogen) cross-linking over time. These studies depict a unique pathology wherein thrombin-catalyzed fibrin polymerization is circumvented to allow tissue deposition and FXIII-dependent fibrin(ogen) cross-linking.

Indexed as

PolymerizationAcetaminophenAnalgesics, Non-NarcoticAnimalsBlood CoagulationChemical and Drug Induced Liver InjuryFactor XIIIFibrinFibrinogenMaleMiceMice, Inbred C57BLMice, KnockoutThrombinAcetaminophenAnalgesics, Non-NarcoticFactor XIIIFibrinFibrinogenThrombin

Identifiers

PMID33569603
PMCPMC8109015
OpenAlexW3126648876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.